0001567619-21-005736.txt : 20210305
0001567619-21-005736.hdr.sgml : 20210305
20210305155524
ACCESSION NUMBER: 0001567619-21-005736
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210303
FILED AS OF DATE: 20210305
DATE AS OF CHANGE: 20210305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smither John W
CENTRAL INDEX KEY: 0001559583
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39186
FILM NUMBER: 21718384
MAIL ADDRESS:
STREET 1: C/O KYTHERA BIOPHARMACEUTICALS, INC.
STREET 2: 27200 WEST AGOURA ROAD, SUITE 200
CITY: CALABASAS
STATE: CA
ZIP: 91301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcutis Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001787306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812974255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3027 TOWNSGATE ROAD
STREET 2: SUITE 300
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
BUSINESS PHONE: 805-418-5006
MAIL ADDRESS:
STREET 1: 3027 TOWNSGATE ROAD
STREET 2: SUITE 300
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
FORMER COMPANY:
FORMER CONFORMED NAME: Arcutis, Inc.
DATE OF NAME CHANGE: 20190905
4
1
doc1.xml
FORM 4
X0306
4
2021-03-03
0
0001787306
Arcutis Biotherapeutics, Inc.
ARQT
0001559583
Smither John W
C/O ARCUTIS BIOTHERAPEUTICS, INC.
3027 TOWNSGATE ROAD, SUITE 300
WESTLAKE VILLAGE
CA
91361
0
1
0
0
Chief Financial Officer
Common Stock
2021-03-03
4
A
0
9500
0
A
33925
D
Common Stock
2021-03-04
4
M
0
12396
1.6806
A
46321
D
Common Stock
87965
I
By Trust
Stock Option (Right to Buy)
32.44
2021-03-03
4
A
0
28800
0.00
A
2031-03-03
Common Stock
28800
28800
D
Stock Option (Right to Buy)
1.6806
2021-03-04
4
M
0
12396
0.00
D
2029-05-14
Common Stock
12396
97684
D
Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on March 3 of each year, beginning March 3, 2022, subject to the Reporting Person's continued service to the Issuer.
Includes 16,250 RSUs.
Reflects cash exercise of stock option without the disposition of the underlying shares.
The securities are held of record by The 1994 Smither Family Trust, as Amended and Restated in 2014, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
1/48th of the shares subject to the option vest on each monthly anniversary measured from March 3, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.
1/4th of the shares subject to the option vest on the one year anniversary measured from May 1, 2019 (the "Vesting Commencement Date"), and 1/48th of the shares vest monthly thereafter such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.
/s/ John W. Smither
2021-03-05